| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.43e-06 | 44 | 111 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 9.17e-06 | 8 | 111 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.95e-05 | 10 | 111 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 4.71e-05 | 71 | 111 | 5 | GO:0042054 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TCF3 PTF1A TBX21 GATA4 ZBTB7B CASZ1 MEN1 KMT2D EGR4 KLF5 SIX5 PRDM16 | 7.36e-05 | 566 | 111 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.78e-04 | 20 | 111 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.75e-04 | 103 | 111 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TCF3 PTF1A TBX21 GATA4 ZBTB7B CASZ1 KMT2D EGR4 KLF5 SIX5 PRDM16 | 2.88e-04 | 560 | 111 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | histone modifying activity | 2.94e-04 | 229 | 111 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 3.01e-04 | 105 | 111 | 5 | GO:0008170 | |
| GeneOntologyMolecularFunction | kinase binding | TCF3 ATN1 TRIP6 MAP2 GATA4 TNS2 SRCIN1 CBL MAP3K1 KIDINS220 ABI2 IGSF9B RAPGEF2 MAPK7 ARHGAP33 | 3.03e-04 | 969 | 111 | 15 | GO:0019900 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 5.60e-04 | 68 | 111 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 5.92e-04 | 69 | 111 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | transcription factor binding | CARM1 VHL TCF3 TRIP6 GATA4 PPP1R13L ZBTB7A KLF5 MAP3K10 BSN PRDM16 CRTC2 | 9.82e-04 | 753 | 111 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.13e-03 | 37 | 111 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | CARM1 ZCCHC18 ATN1 PPP1R13L KMT2C KMT2D ZMIZ2 MAP3K10 AJUBA PRDM16 | 1.17e-03 | 562 | 111 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 1.34e-03 | 10 | 111 | 2 | GO:0034596 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.35e-03 | 86 | 111 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.51e-03 | 582 | 111 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.53e-03 | 303 | 111 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 1.95e-03 | 12 | 111 | 2 | GO:0106019 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 1.95e-03 | 12 | 111 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 2.75e-03 | 172 | 111 | 5 | GO:0008757 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXE1 TCF3 ZNF219 PTF1A RBL2 TBX21 GATA4 KDM6B ZBTB7B ZNF768 CASZ1 ZBTB7A EGR4 KLF5 RBMX SIX5 PRDM16 | 2.83e-03 | 1459 | 111 | 17 | GO:0000977 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CARM1 ZCCHC18 TCF3 ZNF219 RPS6KA4 PTF1A TBX21 GATA4 KDM6B ZBTB7B CASZ1 MAP3K1 MEN1 KMT2C KMT2D EGR4 KLF5 ZMIZ2 RBMX AUTS2 SIX5 MAPK7 PRDM16 PHIP CRTC2 | 8.48e-08 | 1390 | 112 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 7.73e-06 | 185 | 112 | 8 | GO:0099175 | |
| GeneOntologyBiologicalProcess | postsynapse organization | VHL PSD LAMA5 SLITRK3 SRCIN1 SHANK3 PTPRD ABI2 RBMX ARHGAP33 | 8.10e-06 | 313 | 112 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | synapse organization | VHL PSD LAMA5 TSC1 SLITRK3 SRCIN1 SHANK3 PTPRD ABI2 RBMX IGSF9B RAPGEF2 BSN ARHGAP33 | 2.07e-05 | 685 | 112 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 2.55e-05 | 64 | 112 | 5 | GO:0061001 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RAPGEF6 PSD RGL3 SYNPO2L CBL SYDE1 ABI2 HACE1 AUTS2 CGNL1 RAPGEF2 ARHGAP33 | 3.63e-05 | 538 | 112 | 12 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | VHL PSD SLITRK3 SRCIN1 SHANK3 PTPRD ABI2 RBMX RAPGEF2 ARHGAP33 | 4.98e-05 | 387 | 112 | 10 | GO:0050807 |
| GeneOntologyBiologicalProcess | negative regulation of T-helper 17 cell differentiation | 5.43e-05 | 14 | 112 | 3 | GO:2000320 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 5.68e-05 | 123 | 112 | 6 | GO:0032231 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | VHL PSD SLITRK3 SRCIN1 SHANK3 PTPRD ABI2 RBMX RAPGEF2 ARHGAP33 | 5.91e-05 | 395 | 112 | 10 | GO:0050803 |
| GeneOntologyBiologicalProcess | cell junction assembly | PSD TRIP6 TSC1 SLITRK3 SRCIN1 SHANK3 PTPRD ABI2 RAPGEF2 BSN AJUBA ARHGAP33 | 6.22e-05 | 569 | 112 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | negative regulation of T-helper 17 type immune response | 6.76e-05 | 15 | 112 | 3 | GO:2000317 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | PSD MAP2 SYNPO2L TSC1 SLITRK3 SRCIN1 SHANK3 MAP3K1 PDLIM4 PTPRD ABI2 KLF5 AUTS2 CGNL1 RAPGEF2 AJUBA ARHGAP33 SORL1 | 7.08e-05 | 1189 | 112 | 18 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell junction organization | VHL PSD TRIP6 LAMA5 TSC1 SLITRK3 SRCIN1 SHANK3 PTPRD ABI2 RBMX IGSF9B RAPGEF2 BSN AJUBA ARHGAP33 | 7.26e-05 | 974 | 112 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 7.96e-05 | 81 | 112 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | dendrite development | CARM1 MAP2 SRCIN1 SHANK3 KIDINS220 PTPRD ABI2 RAPGEF2 ARHGAP33 | 8.95e-05 | 335 | 112 | 9 | GO:0016358 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.05e-04 | 198 | 112 | 7 | GO:0048813 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.10e-04 | 426 | 112 | 10 | GO:0043010 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 1.53e-04 | 93 | 112 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.58e-04 | 148 | 112 | 6 | GO:0002286 | |
| GeneOntologyBiologicalProcess | negative regulation of T-helper cell differentiation | 2.23e-04 | 22 | 112 | 3 | GO:0045623 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | CARM1 TCF3 LMF1 RAPGEF6 RPS6KA4 TSC1 SRCIN1 SHANK3 SYDE1 MAP3K1 MEN1 ZBTB7A ARAP3 ABI2 MAP3K10 MERTK RAPGEF2 AJUBA CRTC2 | 2.41e-04 | 1430 | 112 | 19 | GO:0044093 |
| GeneOntologyBiologicalProcess | T cell differentiation involved in immune response | 2.47e-04 | 103 | 112 | 5 | GO:0002292 | |
| GeneOntologyBiologicalProcess | eye development | 2.89e-04 | 480 | 112 | 10 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 3.03e-04 | 483 | 112 | 10 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 3.45e-04 | 491 | 112 | 10 | GO:0048880 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell differentiation | 3.70e-04 | 26 | 112 | 3 | GO:0043371 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 4.02e-04 | 410 | 112 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.12e-04 | 115 | 112 | 5 | GO:0097061 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 4.62e-04 | 28 | 112 | 3 | GO:0030033 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 5.19e-04 | 338 | 112 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXE1 VHL TCF3 ZNF219 ATN1 TBX21 GATA4 PPP1R13L ZBTB7B ZC3H6 MEN1 ZBTB7A ZNF469 KLF5 MAP3K10 SIX5 AJUBA PRDM16 | 5.25e-04 | 1399 | 112 | 18 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FOXE1 VHL TCF3 ZNF219 ATN1 TBX21 GATA4 PPP1R13L ZBTB7B MEN1 ZBTB7A ZNF469 KLF5 AJUBA PRDM16 | 5.70e-04 | 1053 | 112 | 15 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXE1 VHL TCF3 ZNF219 ATN1 TBX21 GATA4 PPP1R13L ZBTB7B ZC3H6 MEN1 ZBTB7A ZNF469 KLF5 MAP3K10 SIX5 AJUBA PRDM16 | 5.90e-04 | 1413 | 112 | 18 | GO:1902679 |
| GeneOntologyBiologicalProcess | cellular response to cGMP | 6.03e-04 | 7 | 112 | 2 | GO:0071321 | |
| GeneOntologyBiologicalProcess | sensory organ development | VHL PTF1A ESRP1 BIRC7 PPP1R13L CASZ1 MAP3K1 KMT2C ABI2 SIX5 MERTK PRDM16 | 6.14e-04 | 730 | 112 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 6.19e-04 | 191 | 112 | 6 | GO:0051017 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell differentiation | 6.27e-04 | 31 | 112 | 3 | GO:0046639 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 6.48e-04 | 127 | 112 | 5 | GO:0106027 | |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 6.90e-04 | 195 | 112 | 6 | GO:0061572 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 6.90e-04 | 353 | 112 | 8 | GO:0010721 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell differentiation | 7.55e-04 | 33 | 112 | 3 | GO:2000319 | |
| GeneOntologyBiologicalProcess | microvillus organization | 8.25e-04 | 34 | 112 | 3 | GO:0032528 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 8.25e-04 | 34 | 112 | 3 | GO:0097107 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 3.24e-06 | 75 | 113 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | cell leading edge | PSD ATN1 MAP2 TRPM7 TSC1 SRCIN1 HCN2 PDLIM4 ARAP3 ABI2 AJUBA APBB1IP | 1.70e-05 | 500 | 113 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | neuron to neuron synapse | VHL PSD MAP2 TSC1 SLITRK3 SRCIN1 SHANK3 PRR12 PTPRD RBMX IGSF9B BSN | 2.65e-05 | 523 | 113 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | methyltransferase complex | 2.67e-05 | 108 | 113 | 6 | GO:0034708 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.27e-05 | 12 | 113 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | postsynaptic density | VHL PSD MAP2 TSC1 SLITRK3 SRCIN1 SHANK3 PRR12 RBMX IGSF9B BSN | 3.36e-05 | 451 | 113 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | VHL PSD MAP2 TSC1 SLITRK3 SRCIN1 SHANK3 PRR12 RBMX IGSF9B BSN | 5.58e-05 | 477 | 113 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNB TRIP6 MAP2 SYNPO2L TSC1 SRCIN1 MAP3K1 PDLIM4 ABI2 AUTS2 CGNL1 ARHGAP33 | 6.72e-05 | 576 | 113 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | postsynaptic specialization | VHL PSD MAP2 TSC1 SLITRK3 SRCIN1 SHANK3 PRR12 RBMX IGSF9B BSN | 8.96e-05 | 503 | 113 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | anchoring junction | ILDR2 FLNB ATN1 TRIP6 TNS2 PARD3B SRCIN1 CBL PDLIM4 HEPACAM ABI2 CGNL1 RAPGEF2 AJUBA APBB1IP | 2.46e-04 | 976 | 113 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | lamellipodium | 2.56e-04 | 230 | 113 | 7 | GO:0030027 | |
| GeneOntologyCellularComponent | postsynapse | VHL PSD MAP2 TSC1 SLITRK3 SRCIN1 SHANK3 PDLIM4 PRR12 ABI2 RBMX IGSF9B RAPGEF2 BSN ARHGAP33 | 3.84e-04 | 1018 | 113 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | MLL1/2 complex | 7.46e-04 | 33 | 113 | 3 | GO:0044665 | |
| GeneOntologyCellularComponent | somatodendritic compartment | FLNB PSD MAP2 TRPM7 TBX21 SRCIN1 HCN2 SHANK3 PDLIM4 ABI2 ACAN IGSF9B RAPGEF2 BSN ARHGAP33 SORL1 | 9.24e-04 | 1228 | 113 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | transcription regulator complex | 1.47e-03 | 596 | 113 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | glutamatergic synapse | VHL MAP2 LAMA5 SRCIN1 SHANK3 PTPRD SYNJ1 ABI2 ACAN RBMX BSN ARHGAP33 | 1.56e-03 | 817 | 113 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.17e-03 | 13 | 113 | 2 | GO:0099535 | |
| MousePheno | abnormal brain vasculature morphology | 1.30e-05 | 79 | 92 | 6 | MP:0004950 | |
| MousePheno | abnormal cranial blood vasculature morphology | 3.74e-05 | 95 | 92 | 6 | MP:0014012 | |
| MousePheno | abnormal cerebral artery morphology | 5.49e-05 | 32 | 92 | 4 | MP:0013821 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | FOXE1 CARM1 LMF1 KMT2B PTF1A ESRP1 GATA4 LAMA5 KDM6B HPDL CASZ1 MEN1 KMT2C ZBTB7A KIDINS220 TULP4 SYNJ1 ACAN AUTS2 PRDM16 MN1 | 5.95e-05 | 1269 | 92 | 21 | MP:0011111 |
| Domain | FYrich_C | 1.97e-06 | 5 | 110 | 3 | IPR003889 | |
| Domain | FYrich_N | 1.97e-06 | 5 | 110 | 3 | IPR003888 | |
| Domain | FYRC | 1.97e-06 | 5 | 110 | 3 | SM00542 | |
| Domain | FYRN | 1.97e-06 | 5 | 110 | 3 | SM00541 | |
| Domain | FYRN | 1.97e-06 | 5 | 110 | 3 | PF05964 | |
| Domain | FYRC | 1.97e-06 | 5 | 110 | 3 | PF05965 | |
| Domain | FYRC | 1.97e-06 | 5 | 110 | 3 | PS51543 | |
| Domain | FYRN | 1.97e-06 | 5 | 110 | 3 | PS51542 | |
| Domain | RA | 2.11e-06 | 36 | 110 | 5 | PF00788 | |
| Domain | RA | 2.43e-06 | 37 | 110 | 5 | PS50200 | |
| Domain | RA_dom | 3.61e-06 | 40 | 110 | 5 | IPR000159 | |
| Domain | RA | 3.17e-05 | 31 | 110 | 4 | SM00314 | |
| Domain | Post-SET_dom | 1.05e-04 | 16 | 110 | 3 | IPR003616 | |
| Domain | PostSET | 1.05e-04 | 16 | 110 | 3 | SM00508 | |
| Domain | POST_SET | 1.05e-04 | 16 | 110 | 3 | PS50868 | |
| Domain | SET | 1.54e-04 | 46 | 110 | 4 | SM00317 | |
| Domain | PDZ | 1.87e-04 | 141 | 110 | 6 | PF00595 | |
| Domain | RasGEFN | 2.11e-04 | 20 | 110 | 3 | SM00229 | |
| Domain | SET_dom | 2.13e-04 | 50 | 110 | 4 | IPR001214 | |
| Domain | SET | 2.13e-04 | 50 | 110 | 4 | PS50280 | |
| Domain | PDZ | 2.43e-04 | 148 | 110 | 6 | SM00228 | |
| Domain | RasGEF_N | 2.45e-04 | 21 | 110 | 3 | PF00618 | |
| Domain | - | 2.62e-04 | 150 | 110 | 6 | 2.30.42.10 | |
| Domain | PDZ | 2.71e-04 | 151 | 110 | 6 | PS50106 | |
| Domain | PDZ | 2.81e-04 | 152 | 110 | 6 | IPR001478 | |
| Domain | EPHD | 2.82e-04 | 22 | 110 | 3 | PS51805 | |
| Domain | Ras-like_Gua-exchang_fac_N | 2.82e-04 | 22 | 110 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 2.82e-04 | 22 | 110 | 3 | PS50212 | |
| Domain | - | 3.21e-04 | 449 | 110 | 10 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.82e-04 | 459 | 110 | 10 | IPR013083 | |
| Domain | AT_hook | 5.25e-04 | 27 | 110 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 5.25e-04 | 27 | 110 | 3 | IPR017956 | |
| Domain | RASGEF_CAT | 6.50e-04 | 29 | 110 | 3 | PS50009 | |
| Domain | RasGEF | 7.19e-04 | 30 | 110 | 3 | PF00617 | |
| Domain | - | 7.19e-04 | 30 | 110 | 3 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 7.19e-04 | 30 | 110 | 3 | IPR023578 | |
| Domain | RASGEF_cat_dom | 7.19e-04 | 30 | 110 | 3 | IPR001895 | |
| Domain | RasGEF | 7.19e-04 | 30 | 110 | 3 | SM00147 | |
| Domain | PHD | 1.00e-03 | 75 | 110 | 4 | PF00628 | |
| Domain | cNMP | 1.04e-03 | 34 | 110 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.04e-03 | 34 | 110 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.13e-03 | 35 | 110 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.13e-03 | 35 | 110 | 3 | PS50042 | |
| Domain | SH3_9 | 1.16e-03 | 78 | 110 | 4 | PF14604 | |
| Domain | Znf_PHD-finger | 1.22e-03 | 79 | 110 | 4 | IPR019787 | |
| Domain | cNMP-bd-like | 1.44e-03 | 38 | 110 | 3 | IPR018490 | |
| Domain | Znf_FYVE_PHD | 1.78e-03 | 147 | 110 | 5 | IPR011011 | |
| Domain | SET | 1.80e-03 | 41 | 110 | 3 | PF00856 | |
| Domain | PHD | 1.89e-03 | 89 | 110 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.05e-03 | 91 | 110 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.40e-03 | 95 | 110 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.50e-03 | 96 | 110 | 4 | PS01359 | |
| Domain | - | 2.84e-03 | 48 | 110 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.37e-03 | 51 | 110 | 3 | IPR014710 | |
| Domain | AT_hook | 3.91e-03 | 16 | 110 | 2 | PF02178 | |
| Domain | Ubiquitin-rel_dom | 4.68e-03 | 184 | 110 | 5 | IPR029071 | |
| Domain | Ig_I-set | 5.35e-03 | 190 | 110 | 5 | IPR013098 | |
| Domain | I-set | 5.35e-03 | 190 | 110 | 5 | PF07679 | |
| Domain | RhoGAP | 5.84e-03 | 62 | 110 | 3 | SM00324 | |
| Pathway | WP_INSULIN_SIGNALING | 4.29e-05 | 160 | 83 | 7 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 4.29e-05 | 160 | 83 | 7 | M39482 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 8.34e-05 | 76 | 83 | 5 | MM1433 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.05e-04 | 42 | 83 | 4 | M48018 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.13e-04 | 81 | 83 | 5 | M13863 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 1.26e-04 | 132 | 83 | 6 | M39338 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RAPGEF6 ATN1 TMEM61 TRIP6 NUP214 MAP3K1 KIAA1671 ZNF469 TULP4 KLF5 ZMIZ2 UBQLN3 PIP4P1 PRRG4 IGSF9B BSN AJUBA CRTC2 | 4.33e-15 | 430 | 114 | 18 | 35044719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 KMT2B MORN1 ANXA11 LAMA5 NUP214 KDM6B CASZ1 PLCD3 PRR12 KMT2C KMT2D ARAP3 TULP4 SYNJ1 ZMIZ2 KAZALD1 MMP17 PRDM16 ARHGAP33 PRRC2B | 7.55e-11 | 1105 | 114 | 21 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B ATN1 GATA4 NUP214 KIAA1671 PRR12 KMT2C KMT2D ZMIZ2 AUTS2 PRDM16 PRRC2B | 2.03e-09 | 351 | 114 | 12 | 38297188 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CARM1 ATN1 TRIP6 CPSF6 NUP214 PRR12 KMT2C KMT2D DAZAP1 RBMX AUTS2 PRRC2B CRTC2 | 3.82e-09 | 457 | 114 | 13 | 32344865 |
| Pubmed | TCF3 KMT2B ATN1 TRIP6 GATA4 DIDO1 NUP214 ZNF768 KIAA1671 PRR12 KMT2C ZBTB7A KMT2D KLF5 ZMIZ2 PIP4P1 AUTS2 SIX5 PRDM16 PRRC2B SORL1 | 7.46e-09 | 1429 | 114 | 21 | 35140242 | |
| Pubmed | 4.11e-08 | 152 | 114 | 8 | 38360978 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | RC3H2 RBL2 CASZ1 PRR12 KMT2C KMT2D SYNJ1 ZMIZ2 AUTS2 SIX5 PRDM16 | 8.62e-08 | 398 | 114 | 11 | 35016035 |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 1.37e-07 | 4 | 114 | 3 | 19221051 | |
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.37e-07 | 4 | 114 | 3 | 23129768 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VHL TCF3 EXOSC10 ZNF219 KMT2B SENP3 DIDO1 NUP214 ZBTB7B ZNF768 CASZ1 MEN1 PRR12 KMT2C ZBTB7A KMT2D KLF5 RBMX | 2.26e-07 | 1294 | 114 | 18 | 30804502 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TCF3 RAPGEF6 TRIP6 CPSF6 PLEKHA6 PPP1R13L CBL SYDE1 MAP3K1 SPATA2L ARAP3 KLF5 RAPGEF2 MAPK7 AJUBA CRTC2 | 2.95e-07 | 1038 | 114 | 16 | 26673895 |
| Pubmed | PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. | 3.23e-07 | 18 | 114 | 4 | 17500065 | |
| Pubmed | MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. | 3.41e-07 | 5 | 114 | 3 | 28609655 | |
| Pubmed | TCF3 ZNF219 TBX21 DIDO1 ZBTB7B CBL PDLIM4 KMT2C KLF5 ZMIZ2 SIX5 PRDM16 PHIP | 6.18e-07 | 709 | 114 | 13 | 22988430 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 6.28e-07 | 21 | 114 | 4 | 27626377 | |
| Pubmed | MLL associates specifically with a subset of transcriptionally active target genes. | 6.81e-07 | 6 | 114 | 3 | 16199523 | |
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 6.81e-07 | 6 | 114 | 3 | 17021013 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 7.65e-07 | 22 | 114 | 4 | 26886794 | |
| Pubmed | 1.08e-06 | 233 | 114 | 8 | 37704626 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 30604749 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 19556342 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | VHL ZNF219 ATN1 SENP3 TNS2 PLEKHA6 ZBTB7B SYDE1 ZBTB7A PTPRD DAZAP1 KLF5 KAZALD1 CGNL1 CRTC2 | 1.30e-06 | 1021 | 114 | 15 | 26760575 |
| Pubmed | RC3H2 RAPGEF6 ATN1 SENP3 DIDO1 SYDE1 PLCD3 PRR12 ARAP3 PRRC2B CRTC2 SORL1 | 1.60e-06 | 650 | 114 | 12 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB TCF3 LMF1 MORN1 MAP2 PARD3B SLITRK3 SRCIN1 CASZ1 KIAA1671 KMT2C ZBTB7A KIDINS220 DAZAP1 TULP4 AUTS2 IGSF9B RAPGEF2 | 1.70e-06 | 1489 | 114 | 18 | 28611215 |
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.90e-06 | 8 | 114 | 3 | 23130995 | |
| Pubmed | EXOSC10 RAPGEF6 KMT2B TRIP6 DIDO1 CBL KIAA1671 KMT2C KMT2D SYNJ1 PRRC2B | 2.04e-06 | 549 | 114 | 11 | 38280479 | |
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 22665483 | ||
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 24930734 | ||
| Pubmed | GATA4 SRCIN1 CBL ZC3H6 SHANK3 SYDE1 KMT2C ZBTB7A SYNJ1 ZMIZ2 MMP17 PRRC2B | 2.91e-06 | 689 | 114 | 12 | 36543142 | |
| Pubmed | 3.05e-06 | 268 | 114 | 8 | 33640491 | ||
| Pubmed | ZNF219 PSD ATN1 TRIP6 GATA4 ZNF768 KIAA1671 ZBTB7A ZNF469 RAPGEF2 PRDM16 PHIP ARHGAP33 PRRC2B SORL1 | 3.85e-06 | 1116 | 114 | 15 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 TRIP6 MAP2 TRPM7 PARD3B CBL SYDE1 KIAA1671 SYNJ1 MAP3K10 CGNL1 RAPGEF2 CRTC2 | 5.21e-06 | 861 | 114 | 13 | 36931259 |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | VHL TRIP6 MAPK1IP1L TNS2 ZBTB7B PDLIM4 DAZAP1 ABI2 ZMIZ2 PRRG4 MAPK7 APBB1IP | 6.18e-06 | 742 | 114 | 12 | 26871637 |
| Pubmed | Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. | 7.38e-06 | 12 | 114 | 3 | 17707229 | |
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 27563068 | ||
| Pubmed | KMT2B TRIP6 CPSF6 SENP3 LAMA5 DIDO1 ZBTB7B ZNF768 CASZ1 MEN1 KIAA1671 PLCD3 PRR12 KMT2C ZBTB7A KIDINS220 ABI2 | 7.78e-06 | 1497 | 114 | 17 | 31527615 | |
| Pubmed | 9.58e-06 | 13 | 114 | 3 | 21502505 | ||
| Pubmed | 9.58e-06 | 13 | 114 | 3 | 22286099 | ||
| Pubmed | 1.02e-05 | 418 | 114 | 9 | 34709266 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15096520 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 35640156 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 31924266 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24858808 | ||
| Pubmed | The hcKrox gene family regulates multiple extracellular matrix genes. | 1.07e-05 | 2 | 114 | 2 | 11691585 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 28967912 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 36601880 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 28483418 | ||
| Pubmed | Expression of receptor protein tyrosine phosphatase δ, PTPδ, in mouse central nervous system. | 1.07e-05 | 2 | 114 | 2 | 27026654 | |
| Pubmed | ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma. | 1.07e-05 | 2 | 114 | 2 | 23730213 | |
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 1.07e-05 | 2 | 114 | 2 | 34156443 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 27280393 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 33627571 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 36869380 | ||
| Pubmed | Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders. | 1.07e-05 | 2 | 114 | 2 | 35506254 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 25346535 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 32600317 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.17e-05 | 231 | 114 | 7 | 16452087 | |
| Pubmed | 1.34e-05 | 44 | 114 | 4 | 24183668 | ||
| Pubmed | CARM1 ZNF219 SENP3 DIDO1 TSC1 HCN2 SHANK3 PTPRD SYNJ1 ABI2 RAPGEF2 BSN PRRC2B | 1.71e-05 | 963 | 114 | 13 | 28671696 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNB TRIP6 SRCIN1 NUP214 PLEKHA6 PPP1R13L CBL KIAA1671 KIDINS220 SYNJ1 | 1.78e-05 | 565 | 114 | 10 | 25468996 |
| Pubmed | 1.86e-05 | 16 | 114 | 3 | 24368734 | ||
| Pubmed | 2.24e-05 | 50 | 114 | 4 | 37974198 | ||
| Pubmed | 2.26e-05 | 17 | 114 | 3 | 26180087 | ||
| Pubmed | 2.54e-05 | 469 | 114 | 9 | 27634302 | ||
| Pubmed | 2.70e-05 | 18 | 114 | 3 | 27984743 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.80e-05 | 475 | 114 | 9 | 31040226 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 10826496 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 29248441 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 19801649 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23932714 | ||
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 3.19e-05 | 3 | 114 | 2 | 22183980 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 21949687 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 25053715 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 21683083 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 1720355 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 32544095 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 29747665 | ||
| Pubmed | Menin is necessary for long term maintenance of meningioma-1 driven leukemia. | 3.19e-05 | 3 | 114 | 2 | 33542482 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23358417 | ||
| Pubmed | Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basis. | 3.19e-05 | 3 | 114 | 2 | 27836247 | |
| Pubmed | Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. | 3.19e-05 | 3 | 114 | 2 | 30315824 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 10768861 | ||
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 3.20e-05 | 19 | 114 | 3 | 30385546 | |
| Pubmed | NUP214 PLEKHA6 CBL KMT2C MAP3K10 CGNL1 RAPGEF2 MAPK7 ARHGAP33 | 3.34e-05 | 486 | 114 | 9 | 20936779 | |
| Pubmed | 3.67e-05 | 276 | 114 | 7 | 28319085 | ||
| Pubmed | 3.75e-05 | 20 | 114 | 3 | 19047629 | ||
| Pubmed | 3.78e-05 | 57 | 114 | 4 | 18022353 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 3.86e-05 | 495 | 114 | 9 | 27705803 | |
| Pubmed | 4.70e-05 | 119 | 114 | 5 | 23508102 | ||
| Pubmed | TRIP6 GATA4 NUP214 PPP1R13L ZNF768 SYDE1 KIAA1671 ARAP3 DAZAP1 AJUBA ARHGAP33 SORL1 | 4.90e-05 | 916 | 114 | 12 | 32203420 | |
| Pubmed | 5.79e-05 | 23 | 114 | 3 | 25190801 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 34645806 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 22863532 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 21394196 | ||
| Pubmed | Elimination of von Hippel-Lindau function perturbs pancreas endocrine homeostasis in mice. | 6.36e-05 | 4 | 114 | 2 | 23977255 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 14701864 | ||
| Pubmed | MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. | 6.36e-05 | 4 | 114 | 2 | 26927674 | |
| Pubmed | JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4. | 6.36e-05 | 4 | 114 | 2 | 31393857 | |
| Pubmed | Menin promotes the Wnt signaling pathway in pancreatic endocrine cells. | 6.36e-05 | 4 | 114 | 2 | 19074834 | |
| Interaction | RERE interactions | 5.58e-08 | 93 | 114 | 8 | int:RERE | |
| Interaction | EYA4 interactions | TCF3 ATN1 TRIP6 CPSF6 MAPK1IP1L PRR12 DAZAP1 ZMIZ2 AUTS2 SIX5 PRRC2B | 1.35e-07 | 243 | 114 | 11 | int:EYA4 |
| Interaction | YWHAB interactions | RC3H2 RAPGEF6 RPS6KA4 MAP2 TRPM7 CPSF6 TNS2 PARD3B TSC1 CBL SHANK3 SYDE1 KIAA1671 ABI2 RBMX MAP3K10 CGNL1 MERTK RAPGEF2 MAPK7 CRTC2 | 2.20e-07 | 1014 | 114 | 21 | int:YWHAB |
| Interaction | SORBS3 interactions | 2.26e-07 | 202 | 114 | 10 | int:SORBS3 | |
| Interaction | SON interactions | 2.96e-07 | 208 | 114 | 10 | int:SON | |
| Interaction | NEDD4 interactions | RAPGEF6 RPS6KA4 MAP2 CPSF6 TSC1 KDM6B ZBTB7B CBL SHANK3 TULP4 KLF5 PIP4P1 PRRG4 RAPGEF2 CRTC2 | 4.33e-07 | 544 | 114 | 15 | int:NEDD4 |
| Interaction | IRF4 interactions | 5.28e-07 | 85 | 114 | 7 | int:IRF4 | |
| Interaction | GSC interactions | 6.19e-07 | 87 | 114 | 7 | int:GSC | |
| Interaction | YAP1 interactions | VHL FLNB EXOSC10 RAPGEF6 KMT2B ATN1 TMEM61 TRIP6 MAP2 CPSF6 DIDO1 MEN1 KMT2C KMT2D TULP4 KLF5 PIP4P1 PRRG4 IGSF9B RAPGEF2 AJUBA | 7.73e-07 | 1095 | 114 | 21 | int:YAP1 |
| Interaction | ATN1 interactions | 1.18e-06 | 187 | 114 | 9 | int:ATN1 | |
| Interaction | PIN1 interactions | VHL KMT2B ATN1 TRIP6 TNS2 DIDO1 ZBTB7B ZNF768 DAZAP1 ABI2 ZMIZ2 AJUBA | 1.81e-06 | 383 | 114 | 12 | int:PIN1 |
| Interaction | CRX interactions | 1.83e-06 | 254 | 114 | 10 | int:CRX | |
| Interaction | HDAC1 interactions | VHL FLNB ZNF219 RAPGEF6 KMT2B TRPM7 RBL2 GATA4 NUP214 ZBTB7B CASZ1 MEN1 KIAA1671 ZBTB7A KMT2D SYNJ1 KLF5 ZMIZ2 PRRG4 PRDM16 | 3.71e-06 | 1108 | 114 | 20 | int:HDAC1 |
| Interaction | FXR2 interactions | RC3H2 ATN1 CPSF6 TSC1 NUP214 ZBTB7B MEN1 KIAA1671 DAZAP1 RBMX PRDM16 PRRC2B | 5.92e-06 | 430 | 114 | 12 | int:FXR2 |
| Interaction | FXR1 interactions | FLNB RC3H2 ZNF219 ATN1 CPSF6 DIDO1 TSC1 ZBTB7B SHANK3 MEN1 KIAA1671 DAZAP1 MAPK7 PRDM16 PRRC2B | 6.65e-06 | 679 | 114 | 15 | int:FXR1 |
| Interaction | SOX7 interactions | 7.08e-06 | 82 | 114 | 6 | int:SOX7 | |
| Interaction | PPP3CA interactions | 8.18e-06 | 179 | 114 | 8 | int:PPP3CA | |
| Interaction | KHDRBS1 interactions | RC3H2 CPSF6 GATA4 ZBTB7B CBL SHANK3 MEN1 ZBTB7A ABI2 RBMX PRDM16 | 8.83e-06 | 373 | 114 | 11 | int:KHDRBS1 |
| Interaction | PAX9 interactions | 9.17e-06 | 130 | 114 | 7 | int:PAX9 | |
| Interaction | MEF2D interactions | 9.98e-06 | 87 | 114 | 6 | int:MEF2D | |
| Interaction | CXXC1 interactions | 1.01e-05 | 132 | 114 | 7 | int:CXXC1 | |
| Interaction | GCNT2 interactions | 1.11e-05 | 52 | 114 | 5 | int:GCNT2 | |
| Interaction | TEC interactions | 1.21e-05 | 90 | 114 | 6 | int:TEC | |
| Interaction | PHF20 interactions | 1.23e-05 | 53 | 114 | 5 | int:PHF20 | |
| Interaction | HCFC2 interactions | 1.38e-05 | 92 | 114 | 6 | int:HCFC2 | |
| Interaction | ZNF608 interactions | 1.47e-05 | 93 | 114 | 6 | int:ZNF608 | |
| Interaction | WWP1 interactions | 1.72e-05 | 260 | 114 | 9 | int:WWP1 | |
| Interaction | FEV interactions | 2.04e-05 | 203 | 114 | 8 | int:FEV | |
| Interaction | YWHAG interactions | RC3H2 RAPGEF6 RPS6KA4 MAP2 TRPM7 GATA4 TNS2 PARD3B TSC1 CBL SHANK3 SYDE1 MAP3K1 KIAA1671 SYNJ1 MAP3K10 CGNL1 RAPGEF2 MAPK7 CRTC2 | 2.13e-05 | 1248 | 114 | 20 | int:YWHAG |
| Interaction | TOP3B interactions | RC3H2 RAPGEF6 KMT2B MORN1 ANXA11 LAMA5 NUP214 KDM6B CASZ1 PLCD3 PRR12 KMT2C KMT2D ARAP3 TULP4 SYNJ1 ZMIZ2 KAZALD1 MMP17 PRDM16 ARHGAP33 PRRC2B | 2.24e-05 | 1470 | 114 | 22 | int:TOP3B |
| Interaction | YWHAE interactions | RC3H2 RAPGEF6 TRPM7 TNS2 PARD3B TSC1 SRCIN1 CBL SHANK3 SYDE1 MAP3K1 KIAA1671 ABI2 MAP3K10 CGNL1 MERTK RAPGEF2 MAPK7 ARHGAP33 CRTC2 | 2.34e-05 | 1256 | 114 | 20 | int:YWHAE |
| Interaction | WWTR1 interactions | EXOSC10 RAPGEF6 TRIP6 DIDO1 CBL KIAA1671 KMT2D SYNJ1 KLF5 PRRG4 PRRC2B | 2.77e-05 | 422 | 114 | 11 | int:WWTR1 |
| Interaction | NUP35 interactions | ATN1 TRIP6 CPSF6 NUP214 PRR12 KMT2C KMT2D DAZAP1 AUTS2 PRRC2B CRTC2 | 2.90e-05 | 424 | 114 | 11 | int:NUP35 |
| Interaction | ID2 interactions | 2.93e-05 | 105 | 114 | 6 | int:ID2 | |
| Interaction | LENG8 interactions | 4.12e-05 | 164 | 114 | 7 | int:LENG8 | |
| Interaction | HCFC1 interactions | 4.38e-05 | 293 | 114 | 9 | int:HCFC1 | |
| Interaction | YWHAH interactions | RAPGEF6 RPS6KA4 TRIP6 MAP2 TRPM7 TNS2 PARD3B TSC1 CBL SYDE1 KIAA1671 SYNJ1 ABI2 MAP3K10 CGNL1 RAPGEF2 MAPK7 CRTC2 | 4.55e-05 | 1102 | 114 | 18 | int:YWHAH |
| Interaction | EGR2 interactions | 5.38e-05 | 171 | 114 | 7 | int:EGR2 | |
| Interaction | TLE3 interactions | 5.52e-05 | 376 | 114 | 10 | int:TLE3 | |
| Interaction | SP7 interactions | 5.83e-05 | 304 | 114 | 9 | int:SP7 | |
| Interaction | SMARCA4 interactions | FOXE1 CARM1 TCF3 RBL2 TBX21 GATA4 KDM6B MEN1 ZBTB7A ZMIZ2 PHIP | 6.29e-05 | 462 | 114 | 11 | int:SMARCA4 |
| Interaction | SETD1B interactions | 6.68e-05 | 75 | 114 | 5 | int:SETD1B | |
| Interaction | FOS interactions | 7.11e-05 | 312 | 114 | 9 | int:FOS | |
| Interaction | KMT2A interactions | 7.47e-05 | 314 | 114 | 9 | int:KMT2A | |
| Interaction | ALG13 interactions | 8.24e-05 | 183 | 114 | 7 | int:ALG13 | |
| Interaction | OGT interactions | CARM1 RC3H2 CPSF6 ANXA11 GATA4 TNS2 DIDO1 NUP214 ZNF768 MEN1 KMT2C DAZAP1 ABI2 KLF5 RBMX HCFC1R1 | 8.82e-05 | 950 | 114 | 16 | int:OGT |
| Interaction | EP300 interactions | CARM1 VHL TCF3 MORN1 CPSF6 SENP3 TBX21 GATA4 PPP1R13L ZBTB7B CBL ZNF469 KMT2D KLF5 RBMX AUTS2 BSN AJUBA MN1 CRTC2 | 1.07e-04 | 1401 | 114 | 20 | int:EP300 |
| Interaction | ARL16 interactions | 1.08e-04 | 83 | 114 | 5 | int:ARL16 | |
| Interaction | KMT2C interactions | 1.14e-04 | 134 | 114 | 6 | int:KMT2C | |
| Interaction | TIMM50 interactions | 1.20e-04 | 261 | 114 | 8 | int:TIMM50 | |
| Interaction | NCK2 interactions | 1.23e-04 | 262 | 114 | 8 | int:NCK2 | |
| Interaction | NFKBIB interactions | 1.28e-04 | 86 | 114 | 5 | int:NFKBIB | |
| Interaction | ZNF281 interactions | 1.31e-04 | 197 | 114 | 7 | int:ZNF281 | |
| Interaction | CECR2 interactions | 1.32e-04 | 46 | 114 | 4 | int:CECR2 | |
| Interaction | DDX17 interactions | 1.54e-04 | 426 | 114 | 10 | int:DDX17 | |
| Interaction | XRCC5 interactions | CARM1 VHL RC3H2 SENP3 GATA4 ZBTB7B CBL MEN1 ZBTB7A PRDM16 PHIP | 1.64e-04 | 515 | 114 | 11 | int:XRCC5 |
| Interaction | CTNNB1 interactions | CARM1 TCF3 PARD3B TSC1 SRCIN1 NUP214 PLEKHA6 CBL MEN1 KIAA1671 KMT2D KLF5 ZMIZ2 RBMX CGNL1 RAPGEF2 | 1.77e-04 | 1009 | 114 | 16 | int:CTNNB1 |
| Interaction | YWHAQ interactions | TCF3 RAPGEF6 RPS6KA4 MAP2 TRPM7 PARD3B TSC1 CBL SHANK3 SYDE1 MAP3K1 KIAA1671 MAP3K10 CGNL1 MERTK RAPGEF2 CRTC2 | 1.80e-04 | 1118 | 114 | 17 | int:YWHAQ |
| Interaction | TCF12 interactions | 1.97e-04 | 148 | 114 | 6 | int:TCF12 | |
| Interaction | MYEF2 interactions | 2.28e-04 | 152 | 114 | 6 | int:MYEF2 | |
| Interaction | RBBP5 interactions | 2.29e-04 | 287 | 114 | 8 | int:RBBP5 | |
| Interaction | TFAP4 interactions | 2.36e-04 | 153 | 114 | 6 | int:TFAP4 | |
| Interaction | KIF5A interactions | 2.37e-04 | 98 | 114 | 5 | int:KIF5A | |
| Interaction | RAB39B interactions | 2.84e-04 | 56 | 114 | 4 | int:RAB39B | |
| Interaction | TNIK interactions | 3.18e-04 | 381 | 114 | 9 | int:TNIK | |
| Interaction | CSNK2A1 interactions | VHL KMT2B ATN1 CPSF6 RBL2 SENP3 GATA4 ASIC3 ZBTB7B SHANK3 MEN1 PLCD3 RBMX AUTS2 PRDM16 | 3.20e-04 | 956 | 114 | 15 | int:CSNK2A1 |
| Interaction | KDM6A interactions | 3.21e-04 | 162 | 114 | 6 | int:KDM6A | |
| Interaction | ABL2 interactions | 3.56e-04 | 107 | 114 | 5 | int:ABL2 | |
| Interaction | KMT2D interactions | 4.02e-04 | 169 | 114 | 6 | int:KMT2D | |
| Interaction | SETD1A interactions | 4.15e-04 | 170 | 114 | 6 | int:SETD1A | |
| Interaction | SH3KBP1 interactions | 4.28e-04 | 315 | 114 | 8 | int:SH3KBP1 | |
| Interaction | PDLIM4 interactions | 4.67e-04 | 27 | 114 | 3 | int:PDLIM4 | |
| Interaction | SMAD1 interactions | 4.68e-04 | 243 | 114 | 7 | int:SMAD1 | |
| Interaction | EGR4 interactions | 4.69e-04 | 6 | 114 | 2 | int:EGR4 | |
| Interaction | MEGF11 interactions | 4.69e-04 | 6 | 114 | 2 | int:MEGF11 | |
| Interaction | RBM15 interactions | 4.84e-04 | 175 | 114 | 6 | int:RBM15 | |
| Interaction | CTBP1 interactions | 5.03e-04 | 406 | 114 | 9 | int:CTBP1 | |
| Interaction | ZNF277 interactions | 5.21e-04 | 28 | 114 | 3 | int:ZNF277 | |
| Interaction | FBLN2 interactions | 5.34e-04 | 66 | 114 | 4 | int:FBLN2 | |
| Interaction | P3H2 interactions | 5.79e-04 | 29 | 114 | 3 | int:P3H2 | |
| Interaction | GCM1 interactions | 5.98e-04 | 68 | 114 | 4 | int:GCM1 | |
| Interaction | RBBP7 interactions | 6.11e-04 | 507 | 114 | 10 | int:RBBP7 | |
| Interaction | NPRL2 interactions | 6.26e-04 | 121 | 114 | 5 | int:NPRL2 | |
| Interaction | PFN1 interactions | RAPGEF6 TRIP6 CPSF6 TSC1 CBL KIAA1671 KIDINS220 DAZAP1 SYNJ1 APBB1IP | 6.30e-04 | 509 | 114 | 10 | int:PFN1 |
| Interaction | ETV4 interactions | 6.33e-04 | 69 | 114 | 4 | int:ETV4 | |
| Interaction | GRB2 interactions | MAP2 CPSF6 TNS2 HCN2 ZBTB7B CBL SHANK3 MAP3K1 SPATA2L SYNJ1 PRRG4 MERTK AJUBA | 6.36e-04 | 806 | 114 | 13 | int:GRB2 |
| Interaction | TRAPPC2L interactions | 6.50e-04 | 122 | 114 | 5 | int:TRAPPC2L | |
| Interaction | FRS3 interactions | 6.50e-04 | 122 | 114 | 5 | int:FRS3 | |
| Interaction | KANSL2 interactions | 6.68e-04 | 70 | 114 | 4 | int:KANSL2 | |
| Interaction | ITSN1 interactions | 6.83e-04 | 259 | 114 | 7 | int:ITSN1 | |
| Interaction | GATA3 interactions | 6.86e-04 | 187 | 114 | 6 | int:GATA3 | |
| Interaction | SLC39A7 interactions | 6.86e-04 | 187 | 114 | 6 | int:SLC39A7 | |
| Interaction | TAF1 interactions | 6.99e-04 | 260 | 114 | 7 | int:TAF1 | |
| Interaction | RBPMS interactions | 7.06e-04 | 340 | 114 | 8 | int:RBPMS | |
| Interaction | PHF21A interactions | 7.47e-04 | 343 | 114 | 8 | int:PHF21A | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.64e-05 | 34 | 82 | 4 | 487 | |
| GeneFamily | PDZ domain containing | 6.62e-05 | 152 | 82 | 6 | 1220 | |
| GeneFamily | PHD finger proteins | 7.47e-04 | 90 | 82 | 4 | 88 | |
| GeneFamily | LIM domain containing | 2.43e-03 | 59 | 82 | 3 | 1218 | |
| GeneFamily | Ankyrin repeat domain containing | 4.87e-03 | 242 | 82 | 5 | 403 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.16e-03 | 718 | 82 | 9 | 28 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.26e-03 | 24 | 82 | 2 | 654 | |
| GeneFamily | Fibronectin type III domain containing | 6.05e-03 | 160 | 82 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.18e-03 | 161 | 82 | 4 | 593 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.74e-07 | 177 | 114 | 7 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 4.03e-07 | 179 | 114 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-07 | 189 | 114 | 7 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.76e-06 | 153 | 114 | 6 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-06 | 176 | 114 | 6 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-06 | 182 | 114 | 6 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.48e-06 | 186 | 114 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-06 | 187 | 114 | 6 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-06 | 187 | 114 | 6 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-06 | 187 | 114 | 6 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-06 | 187 | 114 | 6 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-06 | 187 | 114 | 6 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.74e-06 | 187 | 114 | 6 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 187 | 114 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.29e-06 | 189 | 114 | 6 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-06 | 190 | 114 | 6 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-06 | 190 | 114 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-06 | 190 | 114 | 6 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-06 | 190 | 114 | 6 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 191 | 114 | 6 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 191 | 114 | 6 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-05 | 192 | 114 | 6 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-05 | 192 | 114 | 6 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-05 | 192 | 114 | 6 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 193 | 114 | 6 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 193 | 114 | 6 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 198 | 114 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-05 | 200 | 114 | 6 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-05 | 200 | 114 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 5.74e-05 | 160 | 114 | 5 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.91e-05 | 161 | 114 | 5 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.43e-05 | 169 | 114 | 5 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-05 | 170 | 114 | 5 | 4cd3b7e43a061948084c01713ae141b5c2c07d89 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.64e-05 | 170 | 114 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Ionocyte|World / Class top | 7.64e-05 | 170 | 114 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-05 | 170 | 114 | 5 | 36c9f7f98612a72dc511c8da4358d67444f6bcf4 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.24e-05 | 177 | 114 | 5 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 1.00e-04 | 180 | 114 | 5 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-04 | 180 | 114 | 5 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 181 | 114 | 5 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 181 | 114 | 5 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 181 | 114 | 5 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 182 | 114 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 183 | 114 | 5 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 183 | 114 | 5 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-04 | 184 | 114 | 5 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 185 | 114 | 5 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 185 | 114 | 5 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 185 | 114 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 186 | 114 | 5 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.20e-04 | 187 | 114 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 187 | 114 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 187 | 114 | 5 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.23e-04 | 188 | 114 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 188 | 114 | 5 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-04 | 189 | 114 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.26e-04 | 189 | 114 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 190 | 114 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 190 | 114 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.29e-04 | 190 | 114 | 5 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 190 | 114 | 5 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 191 | 114 | 5 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 191 | 114 | 5 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 191 | 114 | 5 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 191 | 114 | 5 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-04 | 191 | 114 | 5 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 1.32e-04 | 191 | 114 | 5 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-04 | 191 | 114 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.32e-04 | 191 | 114 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 192 | 114 | 5 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 192 | 114 | 5 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 192 | 114 | 5 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.35e-04 | 192 | 114 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.35e-04 | 192 | 114 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 192 | 114 | 5 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 192 | 114 | 5 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 192 | 114 | 5 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | droplet-Thymus-nan-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 193 | 114 | 5 | 81871f4f2b63ca5f64a9ff12f6c909a34bf52216 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 193 | 114 | 5 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.39e-04 | 193 | 114 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 193 | 114 | 5 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.39e-04 | 193 | 114 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 194 | 114 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.42e-04 | 194 | 114 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.42e-04 | 194 | 114 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 194 | 114 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 194 | 114 | 5 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 194 | 114 | 5 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 194 | 114 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 195 | 114 | 5 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 195 | 114 | 5 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 196 | 114 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 5.31e-06 | 192 | 113 | 8 | 6990_DN | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 5.95e-06 | 195 | 113 | 8 | 3124_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.95e-06 | 195 | 113 | 8 | 6770_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; PC3; HT_HG-U133A | 6.66e-06 | 198 | 113 | 8 | 4569_DN | |
| Drug | Antigens, Polyomavirus Transforming | EXOSC10 LMF1 TRIP6 TRPM7 CPSF6 TSC1 PPP1R13L CBL KIDINS220 SYNJ1 MN1 PHIP CRTC2 | 2.77e-05 | 668 | 113 | 13 | ctd:D000952 |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 5.11e-05 | 193 | 113 | 7 | 6757_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 5.11e-05 | 193 | 113 | 7 | 4186_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 5.11e-05 | 193 | 113 | 7 | 4241_DN | |
| Drug | Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 6774_DN | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 5330_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 3871_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 3745_UP | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HG-U133A | 5.63e-05 | 196 | 113 | 7 | 384_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 2119_DN | |
| Drug | benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 5.63e-05 | 196 | 113 | 7 | 631_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; PC3; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 4675_DN | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; PC3; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 5834_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 4405_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 2326_DN | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 2161_UP | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 3250_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 6625_UP | |
| Drug | monastrol; Up 200; 100uM; PC3; HG-U133A | 6.00e-05 | 198 | 113 | 7 | 668_UP | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 6592_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 3764_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 3738_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 7296_UP | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 3880_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 7192_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 6.20e-05 | 199 | 113 | 7 | 408_DN | |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | 6.20e-05 | 199 | 113 | 7 | 578_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 1648_DN | |
| Drug | tyrosinal | 9.20e-05 | 18 | 113 | 3 | CID000445993 | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.08e-04 | 183 | 113 | 6 | 3480_UP | |
| Drug | mosidal | 3.19e-04 | 27 | 113 | 3 | CID003032288 | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.36e-04 | 186 | 113 | 6 | 3178_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 3.56e-04 | 188 | 113 | 6 | 1176_DN | |
| Drug | maltol | 3.56e-04 | 28 | 113 | 3 | CID000008369 | |
| Drug | GTX8 | 3.96e-04 | 29 | 113 | 3 | CID000104985 | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.98e-04 | 192 | 113 | 6 | 1792_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 4.09e-04 | 193 | 113 | 6 | 4315_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 7214_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 3910_DN | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 7529_DN | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 6081_DN | |
| Drug | 5155877; Up 200; 10uM; MCF7; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 6549_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 6779_DN | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 6467_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 2520_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.20e-04 | 194 | 113 | 6 | 5952_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 2681_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 6927_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 6796_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 5667_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 5618_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 4199_DN | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 2475_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 4333_DN | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 5911_DN | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; PC3; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 4211_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 4.32e-04 | 195 | 113 | 6 | 1649_DN | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 7527_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 5833_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 5288_UP | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 7181_DN | |
| Drug | Methylatropine nitrate [52-88-0]; Up 200; 11uM; HL60; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 3116_UP | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 2851_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 4560_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HG-U133A | 4.44e-04 | 196 | 113 | 6 | 432_DN | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 6888_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 1338_UP | |
| Drug | LY294002; Down 200; 10uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 5970_DN | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 5257_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 5781_UP | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 5466_UP | |
| Drug | indomethacin, USP; Up 200; 100uM; SKMEL5; HG-U133A | 4.44e-04 | 196 | 113 | 6 | 503_UP | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; PC3; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 4212_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 3315_UP | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; HL60; HG-U133A | 4.44e-04 | 196 | 113 | 6 | 1416_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; HL60; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 2442_UP | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 4.44e-04 | 196 | 113 | 6 | 3383_DN | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; HL60; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 3027_DN | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HG-U133A | 4.56e-04 | 197 | 113 | 6 | 1887_UP | |
| Drug | Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 3143_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 4207_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 4.56e-04 | 197 | 113 | 6 | 1732_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; HL60; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 2433_UP | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; HL60; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 3042_DN | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 6091_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 3786_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; HL60; HG-U133A | 4.56e-04 | 197 | 113 | 6 | 1747_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 4767_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 6732_DN | |
| Drug | troglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 1173_UP | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; HL60; HG-U133A | 4.56e-04 | 197 | 113 | 6 | 2012_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.56e-04 | 197 | 113 | 6 | 5605_UP | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 4.68e-04 | 198 | 113 | 6 | 3754_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 4.68e-04 | 198 | 113 | 6 | 4762_DN | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.68e-04 | 198 | 113 | 6 | 6976_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.68e-04 | 198 | 113 | 6 | 6341_DN | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.53e-06 | 23 | 110 | 4 | C1708353 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.38e-05 | 2 | 110 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | mean arterial pressure | 1.81e-05 | 499 | 110 | 10 | EFO_0006340 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 1.90e-04 | 30 | 110 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.67e-04 | 335 | 110 | 7 | EFO_0009931 | |
| Disease | Colorectal Carcinoma | 3.02e-04 | 702 | 110 | 10 | C0009402 | |
| Disease | prostate cancer (is_marker_for) | 3.03e-04 | 156 | 110 | 5 | DOID:10283 (is_marker_for) | |
| Disease | cognitive function measurement, self reported educational attainment | 3.79e-04 | 355 | 110 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Squamous cell carcinoma of esophagus | 4.48e-04 | 95 | 110 | 4 | C0279626 | |
| Disease | Leukemia, Myelocytic, Acute | 4.87e-04 | 173 | 110 | 5 | C0023467 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 6.08e-04 | 10 | 110 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.38e-04 | 45 | 110 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | pulse pressure measurement | FLNB RC3H2 TRPM7 RGL3 SYNPO2L LAMA5 KDM6B CASZ1 PLCD3 ZBTB7A PTPRD DAZAP1 ABI2 PRDM16 | 6.75e-04 | 1392 | 110 | 14 | EFO_0005763 |
| Disease | 46,XY partial gonadal dysgenesis | 7.41e-04 | 11 | 110 | 2 | C4510744 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 7.46e-04 | 398 | 110 | 7 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | treatment-resistant hypertension | 7.53e-04 | 109 | 110 | 4 | EFO_1002006 | |
| Disease | Carcinoma, Neuroendocrine | 8.87e-04 | 12 | 110 | 2 | C0206695 | |
| Disease | cognitive function measurement | LMF1 ARPP21 RBL2 PARD3B SHANK3 PRR12 KMT2D ARAP3 PTPRD TULP4 ZMIZ2 AUTS2 IGSF9B AJUBA | 9.00e-04 | 1434 | 110 | 14 | EFO_0008354 |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 1.05e-03 | 13 | 110 | 2 | EFO_0020131 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.25e-03 | 125 | 110 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.25e-03 | 125 | 110 | 4 | C1879321 | |
| Disease | Carcinoma of Endocrine Gland | 1.40e-03 | 15 | 110 | 2 | C1704374 | |
| Disease | Intellectual Disability | 1.46e-03 | 447 | 110 | 7 | C3714756 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.57e-03 | 133 | 110 | 4 | EFO_0010092 | |
| Disease | pancreatic ductal carcinoma (is_implicated_in) | 1.60e-03 | 16 | 110 | 2 | DOID:3587 (is_implicated_in) | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 1.60e-03 | 16 | 110 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.81e-03 | 17 | 110 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.81e-03 | 17 | 110 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.81e-03 | 17 | 110 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.81e-03 | 17 | 110 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.81e-03 | 17 | 110 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.81e-03 | 17 | 110 | 2 | C0751781 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.85e-03 | 139 | 110 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 1.90e-03 | 140 | 110 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.95e-03 | 141 | 110 | 4 | C0005684 | |
| Disease | Feeding difficulties | 2.03e-03 | 18 | 110 | 2 | C0232466 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.03e-03 | 18 | 110 | 2 | C0751779 | |
| Disease | non-word reading | 2.03e-03 | 67 | 110 | 3 | EFO_0005299 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.21e-03 | 69 | 110 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.32e-03 | 148 | 110 | 4 | C0279702 | |
| Disease | p-tau measurement | 2.49e-03 | 72 | 110 | 3 | EFO_0004763 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.76e-03 | 21 | 110 | 2 | C1292769 | |
| Disease | Infiltrating duct carcinoma of female breast | 2.76e-03 | 21 | 110 | 2 | C3165106 | |
| Disease | Paroxysmal atrial fibrillation | 2.81e-03 | 156 | 110 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.81e-03 | 156 | 110 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.81e-03 | 156 | 110 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 3.08e-03 | 160 | 110 | 4 | C0004238 | |
| Disease | reading and spelling ability | 3.51e-03 | 166 | 110 | 4 | EFO_0005301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRASPPPPPAFPSRY | 536 | Q8NDL9 | |
| SPPPTDPGDRFPFSF | 741 | Q8WWN8 | |
| PGYPGSGTVTPAVPP | 171 | P50995 | |
| PDYFSPRDVPGPPRA | 701 | Q96RT6 | |
| EAPRYEGSFPAGPPP | 81 | Q96IF1 | |
| PTPTPYFPILAGRGS | 796 | Q86V15 | |
| GAPYPFPPVPTVTTS | 596 | P54259 | |
| TATPPGYKPGSPPSF | 651 | P54259 | |
| GYKPGSPPSFRTGTP | 656 | P54259 | |
| PPFEPGSAVATVPPY | 861 | P54259 | |
| DFVPPPPPSYAGIAG | 581 | Q7Z5R6 | |
| PSVPASGYPELPTPR | 191 | Q96CA5 | |
| AGRGAPPPPPPFTSY | 251 | Q96EP5 | |
| GFVAFLPYRGPEPPP | 641 | Q8IWY9 | |
| SGETPEPPSGPVYPS | 566 | Q9UBL0 | |
| TPPTIGGSLPYRRPP | 361 | Q9NYB9 | |
| PSPPGSPNSLGYFPT | 606 | Q6NXG1 | |
| TGYYPPPPTVPAGVA | 616 | Q9HBD1 | |
| SRSAPPTRGPPPSYG | 291 | P38159 | |
| SAPFLTPGPGRYFPE | 96 | A8MYP8 | |
| SPAPDPPGGLTYFPV | 66 | O00255 | |
| FGFSPGPTPTPEPTT | 56 | Q96EP9 | |
| APPLSPYPFVRTGSP | 1031 | Q08999 | |
| PYPVSSPAAGVPGPR | 296 | Q5T089 | |
| PGSSTPGVLPYFPPG | 676 | Q13164 | |
| SPSPPRAGPFGYPRD | 971 | Q8TEW8 | |
| EGPPRAPSGYSQPPS | 1086 | Q9ULH0 | |
| PPEFPGRPTTLTFAP | 871 | Q02779 | |
| PPTGARPSPGPDYLR | 26 | Q96I82 | |
| PPGTPRPGISVPYSQ | 2206 | Q8NEZ4 | |
| AFTRPPPPYPGNIRS | 2431 | Q8NEZ4 | |
| PSAPSERYPGGSPIP | 1301 | Q9BY89 | |
| PYPLFPGPFPGSLQT | 31 | Q12866 | |
| PLPTTQYSPGPPSGA | 831 | O15054 | |
| QSSSPFYGPRDPEPP | 1936 | Q9UPA5 | |
| NPFFRYTGTTPSPPP | 471 | Q86X55 | |
| PGSPYTVEASLPPDP | 1026 | O75369 | |
| PPFEPPGPGSYENLS | 406 | Q8IYU2 | |
| GISPLPGGERFPYPS | 1051 | Q8WXX7 | |
| AAPGPGPSTFSFVPP | 511 | P35658 | |
| VSTFSGRSPPAPPPY | 2281 | Q9UMN6 | |
| VYSPPGSPPPGDPRI | 341 | O75676 | |
| YEPEPSDPLGSPSPS | 291 | Q9UHC3 | |
| FLEGPAPTPPPGLSY | 171 | Q05215 | |
| YPSTFTPPPLLRFPG | 2881 | O15230 | |
| PPPGPVPYLGTFLTD | 416 | Q3MIN7 | |
| VPYGDPRDTGPSVFP | 656 | Q68CR7 | |
| LIEPSGEPPGTPYFS | 1991 | P16112 | |
| PFLPGFRPVSSAPGP | 141 | Q96IR7 | |
| TRSPSPSDPDYGLPP | 261 | Q7RTS3 | |
| GLYPLGPPSFQPSSP | 1051 | O14559 | |
| PPPVSPRFSFPGTTG | 101 | P43694 | |
| PPDGYPIIPTSGSVP | 616 | Q01780 | |
| PTSDSRGPPPTDPYG | 371 | Q16630 | |
| GTSFSENGPPFPPPV | 66 | Q0VF96 | |
| DTYPGPTPPSILPSR | 186 | Q53ET0 | |
| GPPPYGDSRGPSPSY | 1816 | Q9BTC0 | |
| APEPRSATEPGPPGY | 326 | Q14CZ8 | |
| DTPSPPYPATPAGDI | 121 | Q9NWW0 | |
| PPPDRPYSVGAESRP | 546 | P22681 | |
| PGAPASPRAPRTSPY | 781 | Q9UL51 | |
| GPSPRPPATAYDAPA | 201 | Q8WUF5 | |
| SAPPYGAAFPPFPEG | 41 | Q86T03 | |
| GPGPYSPSVQFRTLP | 1001 | P23468 | |
| PAPTGSYPTPGLYPT | 206 | Q8NDC0 | |
| YPGLPGEFTPPVPDS | 491 | Q10571 | |
| GEFTPPVPDSFPSGP | 496 | Q10571 | |
| PPRRAPSPDGFSPYS | 286 | Q13233 | |
| FTPGFRPTPATTPEP | 21 | P0C841 | |
| GPPSPTSFRPYEVGP | 241 | Q6ZW31 | |
| YIPAPSRPVTPGGAP | 551 | Q9H987 | |
| PDPEFSGKSYSPPVP | 701 | Q92673 | |
| YREPPPTPPGYLGIS | 1501 | Q8TEU7 | |
| FGGRRPPPQPPTPDY | 11 | Q96IW2 | |
| SLYGEPSPGPDSPPA | 241 | Q8IUW3 | |
| SEGPPGTAYPPAPRP | 321 | A5PKW4 | |
| PGPAGYSTARPTIPP | 1186 | O43426 | |
| FPGAVPAARPPYPGA | 181 | O00358 | |
| GYPRPVSDFSLPPGG | 416 | Q9ULZ9 | |
| TFPALTPGFPGIFPP | 506 | Q9HAZ2 | |
| TPGFPGIFPPSLYPR | 511 | Q9HAZ2 | |
| PSLGSPYGQPPRFPV | 131 | P50479 | |
| PTSASPYEFSPPGGP | 636 | O94933 | |
| PYEFSPPGGPVPLSV | 641 | O94933 | |
| LSPPPGYPTGLSPTS | 456 | Q8N196 | |
| YNFSGAAPGPPPPER | 266 | Q9ULL5 | |
| GPPIPSPGFSSFPGV | 26 | Q6UX06 | |
| PAYEGDTPAPPTPTG | 66 | Q6UX72 | |
| PTPPGYIGIPITDFP | 1401 | Q9Y4G8 | |
| PGPGIPPAYSSPRRE | 16 | Q9H4L4 | |
| VSFPVAEGPPTPPAY | 136 | Q8N0U2 | |
| PYPGTIPAAPTTAAP | 836 | Q9NRJ4 | |
| ASEPGSPYPEGPRVP | 246 | Q9Y2H5 | |
| PTRVGFGSGQPPPYD | 591 | Q92574 | |
| ASPLPASPYGGPTPA | 141 | Q15654 | |
| YLAEPPGSPTPGPFS | 56 | Q6ZUT4 | |
| RKPPAFYTSASPPGP | 446 | P61129 | |
| PPTGTASPPEGPQSY | 256 | O15156 | |
| LPFVGPGPPRAEYPS | 531 | A2A3L6 | |
| GRPPESPVNYGSPPS | 131 | Q8WWQ0 | |
| PHSPYSGPPSRGSPV | 491 | Q9C0H9 | |
| PAFSPPPPPGRAYDT | 836 | Q9BYB0 | |
| VPPGLPSSVYPPSSG | 176 | P15923 | |
| TTLATGYPSPPPGPA | 1276 | Q9UPX0 | |
| YPPSVSGVPGPYSIP | 246 | Q71H61 | |
| PDSTFDPEYPGPPRT | 646 | Q8N3E9 | |
| FDGEPQPYPTLPPGT | 91 | P40337 | |
| PGYEPRSPGYEPRSP | 126 | Q9H5H4 | |
| PSGGPVPSPQTYRPS | 2146 | Q5JSZ5 | |
| VSPPPPYPGHTKGFR | 201 | Q9BZD6 | |
| PPSYSSRTPGTPGTP | 1606 | P11137 | |
| TPGTPSYPRTPHTPG | 1616 | P11137 | |
| SIPGYPSSPLPGNPT | 361 | Q8NF64 | |
| APYPTPPGGPLAATR | 446 | Q96JG9 | |
| YPSLTPTGAPPFRGR | 286 | P0CG32 | |
| GPSPGSLPQPSSIYP | 111 | Q9H347 | |
| SPYPGGALVPAPPSR | 56 | Q9UL17 | |
| PFTPVPPRGEPVTVY | 1571 | Q96QT4 | |
| PRAGSISPGSPPYPQ | 826 | Q63HR2 | |
| PYARVPSGETPPSPS | 686 | Q9P2Y4 | |
| GLDFYGPGPPAERPP | 216 | O95365 | |
| QATYFPPSPPSSEPG | 296 | Q13887 | |
| TAPPTYPPYPSPTGA | 2191 | O14686 | |
| SVGVPPPASPSYPRA | 971 | Q9P206 | |
| GYSDPEPESPPAPGR | 21 | Q96S06 |